Shu-zhen Chen

Chinese Academy Of Medical Sciences & Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Application of small interfering RNAs and drug combination for pancreatic cancer therapy.

Application of small interfering RNAs and drug combination for pancreatic cancer therapy.

Journal: Journal of drug targeting
Published: May 31, 2026

Y320 suppresses non-small cell lung cancer growth by triggering autophagy-dependent pyroptosis through ubiquitin/proteasome-mediated c-FLIP degradation.

Y320 suppresses non-small cell lung cancer growth by triggering autophagy-dependent pyroptosis through ubiquitin/proteasome-mediated c-FLIP degradation.

Journal: European journal of pharmacology
Published: January 06, 2026

YKL-06-061 exerts antitumor effect through G1/S phase arrest by downregulating c-Myc and inhibition of metastasis via SIK1 upregulation in pancreatic cancer.

YKL-06-061 exerts antitumor effect through G1/S phase arrest by downregulating c-Myc and inhibition of metastasis via SIK1 upregulation in pancreatic cancer.

Journal: Anti-cancer drugs
Published: December 03, 2024

Author Correction: c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression.

Author Correction: c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression.

Journal: Acta pharmacologica Sinica
Published: July 23, 2024

Chromomycins from soil-derived Streptomyces sp. inhibit the growth of human non-small cell lung cancer cells by targeting c-FLIP.

Chromomycins from soil-derived Streptomyces sp. inhibit the growth of human non-small cell lung cancer cells by targeting c-FLIP.

Journal: Journal of Asian natural products research
Published: July 08, 2024

Thiostrepton suppresses triple-negative breast cancer through downregulating c-FLIP/SMAD2/3 signaling pathway.

Thiostrepton suppresses triple-negative breast cancer through downregulating c-FLIP/SMAD2/3 signaling pathway.

Journal: Journal of Asian natural products research
Published: April 18, 2024

FASN Inhibitors Enhance Bestatin-Related Tumor Cell Apoptosis Through Upregulating PEPT1.

FASN Inhibitors Enhance Bestatin-Related Tumor Cell Apoptosis Through Upregulating PEPT1.

Journal: Current molecular pharmacology
Published: July 26, 2022

Brown adipocytes promote epithelial mesenchymal transition of neuroblastoma cells by inducing PPAR-γ/UCP2 expression.

Brown adipocytes promote epithelial mesenchymal transition of neuroblastoma cells by inducing PPAR-γ/UCP2 expression.

Journal: Adipocyte
Published: May 09, 2022

Thymidine Kinase 1 Mediates the Synergistic Antitumor Activity of Ubenimex and Celecoxib via Regulation of Cell Cycle in Colorectal Cancer.

Thymidine Kinase 1 Mediates the Synergistic Antitumor Activity of Ubenimex and Celecoxib via Regulation of Cell Cycle in Colorectal Cancer.

Journal: The Journal of pharmacology and experimental therapeutics
Published: January 20, 2022

c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression.

c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression.

Journal: Acta pharmacologica Sinica
Published: October 20, 2021

Magnolol inhibits myotube atrophy induced by cancer cachexia through myostatin signaling pathway in vitro.

Magnolol inhibits myotube atrophy induced by cancer cachexia through myostatin signaling pathway in vitro.

Journal: Journal of natural medicines
Published: March 09, 2020

Levamisole enhances DR4-independent apoptosis induced by TRAIL through inhibiting the activation of JNK in lung cancer.

Levamisole enhances DR4-independent apoptosis induced by TRAIL through inhibiting the activation of JNK in lung cancer.

Journal: Life sciences
Published: March 02, 2020
Showing 1-12 of 26

Last Updated: 09/26/2026